Skip to Main Content
Advertisement
Close
AACR Journals
Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics
For Authors
Information for Authors
Author Services
Journal Awards
Best of: Author Profiles
About Us
AACR Journals
Advertising
Permissions & Reprints
Subscriptions
Submit
Article Collections
Journal Collections
Hot Topics
'Best Of' Collection
Editors' Picks
COVID-19
Webinars
Search Dropdown Menu
header search
search input
Search input auto suggest
Search
Advanced Search
User Tools Dropdown
Register
Sign In
Toggle Menu
Menu
About
The Journal
AACR Journals
Subscriptions
Permissions and Reprints
Articles
Online First
Issues
CCR Focus Archives
Meeting Abstracts
Collection: Clinical Trials
Collection: Sarcoma
Collection: Lymphoma
Collection: Breast Cancer
Collection: Immunotherapy: Facts and Hopes
Collection: Editors' Picks
Collection: 'Best 'Of' Collection
For Authors
Information for Authors
Author Services
Best of: Author Profiles
Submit
Alerts
News
COVID-19
Webinars
Skip Nav Destination
Issues
Select Year
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
Issue
1 January - Volume 12, Issue 1, Pages 1 - 322
15 January - Volume 12, Issue 2, Pages 323 - 671
1 February - Volume 12, Issue 3, Pages 673 - 996
15 February - Volume 12, Issue 4, Pages 1069 - 1394
1 March - Volume 12, Issue 5, Pages 1395 - 1656
15 March - Volume 12, Issue 6, Pages 1657 - 1947
1 April - Volume 12, Issue 7, Pages 1949 - 2289
15 April - Volume 12, Issue 8, Pages 2385 - 2649
1 May - Volume 12, Issue 9, Pages 2651 - 2950
15 May - Volume 12, Issue 10, Pages 2951 - 3229
1 June - Volume 12, Issue 11, Pages 3231 - 3552
15 June - Volume 12, Issue 12, Pages 3645 - 3869
1 July - Volume 12, Issue 13, Pages 3871 - 4130
15 July - Volume 12, Issue 14, Pages 4131 - 4364
1 August - Volume 12, Issue 15, Pages 4459 - 4785
15 August - Volume 12, Issue 16, Pages 4787 - 5002
1 September - Volume 12, Issue 17, Pages 5003 - 5254
15 September - Volume 12, Issue 18, Pages 5255 - 5603
1 October - Volume 12, Issue 19, Pages 5605 - 5918
1 October - Volume 12, Issue 19_Supplement
15 October - Volume 12, Issue 20, Pages 5919 - 6206
1 November - Volume 12, Issue 21, Pages 6321 - 6589
15 November - Volume 12, Issue 22, Pages 6591 - 6863
1 December - Volume 12, Issue 23, Pages 6865 - 7201
15 December - Volume 12, Issue 24, Pages 7203 - 7497
Volume 12, Issue 19_Supplement
1 October 2006
ISSN 1078-0432
EISSN 1557-3265
Close navigation menu
In this Issue
Preclinical Studies and Early Drug Development: Target Identification, Validation, Lead Discovery, and Optimization
Diagnostic Technologies and Molecular and Cellular Profiling: Biomarkers in Early Detection and Diagnosis
Targeted Therapies and Clinical Translational Research: Determinants of Recurrence, Survival, and Response to Treatment
Diagnostic Technologies and Molecular and Cellular Profiling: Determinants of Patient Prognosis
Targeted Therapies and Clinical Translational Research: Combination Therapies
Invited Abstract (Plenary Session): Monitoring Response During Cancer Therapy
Diagnostic Technologies and Molecular and Cellular Profiling: Detection of Circulating Tumor Cells or Endothelial Cells/Progenitors
Invited Abstract (Plenary Session): Germline Determinants of Therapeutic Efficacy and Toxicity
Proffered Abstract (Plenary Session): Determinants of Patient Prognosis
Diagnostic Technologies and Molecular and Cellular Profiling: Genomics-Expression Profiling in Tumors and Model Systems
Targeted Therapies and Clinical Translational Research: Patient Selection/Stratification
Targeted Therapies and Clinical Translational Research: Drug Sensitivity and Resistance
Diagnostic Technologies and Molecular and Cellular Profiling: Biomarker Assay Development, Validation, and Qualification
Preclinical Studies and Early Drug Development: Pharmacology, Pharmacogenetics, and Pharmacogenomics
Diagnostic Technologies and Molecular and Cellular Profiling: Methylation Profiling, Epigenetics, and Chromatin Regulation
Diagnostic Technologies and Molecular and Cellular Profiling: Novel Assay Technologies
Preclinical Studies and Early Drug Development: Predicting Tumor Response to Cytotoxic Therapy
Diagnostic Technologies and Molecular and Cellular Profiling: Proteomics
Targeted Therapies and Clinical Translational Research: Optimization of Clinically Effective Dose and Schedule
Preclinical Studies and Early Drug Development: Predicting Drug Efficacy and Risk of Adverse Events
Diagnostic Technologies and Molecular and Cellular Profiling: Other Technologies
Diagnostic Technologies and Molecular and Cellular Profiling: Nanotechnology
Targeted Therapies and Clinical Translational Research: Monitoring Response to Therapy
Diagnostic Technologies and Molecular and Cellular Profiling: Functional and Molecular Imaging In Vivo and In Vitro
Targeted Therapies and Clinical Translational Research: Molecular Endpoints in Clinical Trials
Preclinical Studies and Early Drug Development: In Vitro and In Vivo Assays and Models
Proffered Abstract (Plenary Session): Monitoring Response During Cancer Therapy
Targeted Therapies and Clinical Translational Research: Clinical Pharmacology, Pharmacogenetics, and Pharmacogenomics
Proffered Abstract (Plenary Session): Successes in Developing Tumor Determinants for Targeted Therapies: Lessons Learned
Invited Abstract (Plenary Session): The Emerging Impact of Novel Preclinical Models
Targeted Therapies and Clinical Translational Research: Other Therapies
Proffered Abstract (Plenary Session): Predictive Determinants of Tumor Response to Cytotoxic Therapies
Preclinical Studies and Early Drug Development: Proof-of-Concept Studies
Targeted Therapies and Clinical Translational Research: Clinical Trial Methodology/Design
Invited Abstract (Plenary Session): Determination of Clinicially Effective Dose and Schedule
Invited Abstract (Plenary Session): Regulatory Integration of Diagnostic Markers and Therapeutic Trials
Proffered Abstract (Plenary Session): Germline Determinants of Therapeutic Efficacy and Toxicity
Invited Abstract (Plenary Session): Successes in Developing Tumor Determinants for Targeted Therapies: Lessons Learned
Invited Abstract (Keynote Address): Keynote Address
Invited Abstract (Plenary Session): Determinants of Patient Prognosis
Preclinical Studies and Early Drug Development: Other Preclinical Studies
Invited Abstract (Educational Session): Primer on New Frontiers in Diagnostic Technologies
Diagnostic Technologies and Molecular and Cellular Profiling: Bioinformatics
Invited Abstract (Plenary Session): Predictive Determinants of Tumor Response to Cytotoxic Therapies
Issue Navigation
Search within issue:
Search within issue
First AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, Sep 12-15, 2006
Preclinical Studies and Early Drug Development: Target Identification, Validation, Lead Discovery, and Optimization
Diagnostic Technologies and Molecular and Cellular Profiling: Biomarkers in Early Detection and Diagnosis
Targeted Therapies and Clinical Translational Research: Determinants of Recurrence, Survival, and Response to Treatment
Diagnostic Technologies and Molecular and Cellular Profiling: Determinants of Patient Prognosis
Targeted Therapies and Clinical Translational Research: Combination Therapies
Invited Abstract (Plenary Session): Monitoring Response During Cancer Therapy
Diagnostic Technologies and Molecular and Cellular Profiling: Detection of Circulating Tumor Cells or Endothelial Cells/Progenitors
Invited Abstract (Plenary Session): Germline Determinants of Therapeutic Efficacy and Toxicity
Proffered Abstract (Plenary Session): Determinants of Patient Prognosis
Diagnostic Technologies and Molecular and Cellular Profiling: Genomics-Expression Profiling in Tumors and Model Systems
Targeted Therapies and Clinical Translational Research: Patient Selection/Stratification
Targeted Therapies and Clinical Translational Research: Drug Sensitivity and Resistance
Diagnostic Technologies and Molecular and Cellular Profiling: Biomarker Assay Development, Validation, and Qualification
Preclinical Studies and Early Drug Development: Pharmacology, Pharmacogenetics, and Pharmacogenomics
Diagnostic Technologies and Molecular and Cellular Profiling: Methylation Profiling, Epigenetics, and Chromatin Regulation
Diagnostic Technologies and Molecular and Cellular Profiling: Novel Assay Technologies
Preclinical Studies and Early Drug Development: Predicting Tumor Response to Cytotoxic Therapy
Diagnostic Technologies and Molecular and Cellular Profiling: Proteomics
Targeted Therapies and Clinical Translational Research: Optimization of Clinically Effective Dose and Schedule
Preclinical Studies and Early Drug Development: Predicting Drug Efficacy and Risk of Adverse Events
Diagnostic Technologies and Molecular and Cellular Profiling: Other Technologies
Diagnostic Technologies and Molecular and Cellular Profiling: Nanotechnology
Targeted Therapies and Clinical Translational Research: Monitoring Response to Therapy
Diagnostic Technologies and Molecular and Cellular Profiling: Functional and Molecular Imaging In Vivo and In Vitro
Targeted Therapies and Clinical Translational Research: Molecular Endpoints in Clinical Trials
Preclinical Studies and Early Drug Development: In Vitro and In Vivo Assays and Models
Proffered Abstract (Plenary Session): Monitoring Response During Cancer Therapy
Targeted Therapies and Clinical Translational Research: Clinical Pharmacology, Pharmacogenetics, and Pharmacogenomics
Proffered Abstract (Plenary Session): Successes in Developing Tumor Determinants for Targeted Therapies: Lessons Learned
Invited Abstract (Plenary Session): The Emerging Impact of Novel Preclinical Models
Targeted Therapies and Clinical Translational Research: Other Therapies
Proffered Abstract (Plenary Session): Predictive Determinants of Tumor Response to Cytotoxic Therapies
Preclinical Studies and Early Drug Development: Proof-of-Concept Studies
Targeted Therapies and Clinical Translational Research: Clinical Trial Methodology/Design
Invited Abstract (Plenary Session): Determination of Clinicially Effective Dose and Schedule
Invited Abstract (Plenary Session): Regulatory Integration of Diagnostic Markers and Therapeutic Trials
Proffered Abstract (Plenary Session): Germline Determinants of Therapeutic Efficacy and Toxicity
Invited Abstract (Plenary Session): Successes in Developing Tumor Determinants for Targeted Therapies: Lessons Learned
Invited Abstract (Keynote Address): Keynote Address
Invited Abstract (Plenary Session): Determinants of Patient Prognosis
Preclinical Studies and Early Drug Development: Other Preclinical Studies
Invited Abstract (Educational Session): Primer on New Frontiers in Diagnostic Technologies
Diagnostic Technologies and Molecular and Cellular Profiling: Bioinformatics
Invited Abstract (Plenary Session): Predictive Determinants of Tumor Response to Cytotoxic Therapies
All Issues
Advertisement
Email alerts
Online First Alert
eTOC Alert
Close Modal
Latest
Most Read
Most Cited
Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies
Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
NBN
Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and
In Vitro
DNA Damage Response Defects
Clinical Implications of APOBEC3-mediated Mutagenesis in Breast Cancer
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to
our privacy policy.
Accept
